Metagenomic next-generation sequencing-assisted diagnosis of a rare case of primary cutaneous acanthamoebiasis in an HIV patient: a case report

1 Introduction

Acanthamoeba is widely present in the air and soil and can be isolated from swimming pools, water pipes, and even from the oral and nasal mucosa of healthy people (Siddiqui and Khan, 2012; Borecka et al., 2020). The life cycle of Acanthamoeba has two phases: cyst and trophozoite stage. Trophozoites are the active form, and cysts are the dormant form. Acanthamoeba species are opportunistic and nonopportunistic pathogens that often cause severe and even fatal consequences. Lens wearers are predisposed to amoebic infection, which may lead to amoebic keratitis and blindness. Acanthamoeba infection involving the central nervous system leads to amoebic encephalitis and brain necrosis. Its prognosis is poor, and most patients die within less than one month after the patient has experienced neurological symptoms (Marciano-Cabral and Cabral, 2003).

The pathogenic mechanism of Acanthamoeba infection is still unclear and may be related to the host immune status. Interestingly, immunocompromised patients present simple cutaneous lesions with a good prognosis, while immunocompetence usually leads to serious consequences (Galarza et al., 2009).

Acanthamoeba species are also hosts of pathogenic microorganisms. Bacteria, fungi, and viruses can live symbiotically within Acanthamoeba (Rayamajhee et al., 2021). Interactions between Acanthamoeba and endosymbionts exhibit variable capabilities, and it has been shown that the presence of endosymbionts enhances the pathogenicity of Acanthamoeba (Purssell et al., 2017). According to previous studies of commensal pathogens of Acanthamoeba keratitis, endosymbiotic bacteria may enhance corneal epithelial damage, increasing stromal infiltration and epithelial defects. These pathogens divide and survive within the cytoplasm of Acanthamoeba, and their interaction with the amoeba may be clinically significant (Rayamajhee et al., 2022).

As an emerging technology in recent years, mNGS can detect multiple microorganisms at one time, without preassuming pathogens and quickly locating suspected pathogenic microorganisms, and then provides evidence-based, reference information about diagnosis, drugs and toxicology for clinicians. Currently, this technique plays an important role in the diagnosis of fever of unknown origin (FUO), acute and severe symptoms, and difficult infections. Here, we report the case of a 63-year-old female patient infected with HIV who presented with oral leukoplakia and giant skin ulcers. Acanthamoeba was detected through mNGS, and the skin ulcers improved after treatment.

2 Case presentation

A 63-year-old female patient had 4-month history of oral leukoplakia with 2-month nonhealing, large cutaneous ulcerations all over the body. The patient was diagnosed with HIV infection 2 years ago. Physical examination revealed numerous cases of leukoplakia on the oral mucosa and a 1 cm fistula on the palate. The scattered skin ulcers were mainly on the bilateral buttocks and proximal extremities, and the largest ulcer was approximately 4*4 cm in the right buttock. The patient visited the local county hospital four months prior for oral leukoplakia and was considered to have an oral fungal infection. Oral leukoplakia improved after antifungal symptomatic treatment. However, the tumor recurred after drug withdrawal, and the hard palate abscess gradually ruptured. Three months later, oral leukoplakia recurred accompanied by multiple skin lumps, so she sought treatment again.

A series of laboratory tests were performed. The blood test results were as follows: white blood cell count 2.30*10⁹/L, red blood cell count 2.38*10¹²/L, and hemoglobin level 74 g/L. The absolute lymphocyte count was 0.2*10⁹/L. The absolute count of CD4 T lymphocyte was 4 cells/μl. Her C-reactive protein (CRP) level was 21.7 mg/L. The erythrocyte sedimentation rate (ESR) was 27 mm/h. Her procalcitonin level was normal. The activated partial thromboplastin time was 38 seconds, the thrombin time was 19.5 seconds, and the fibrinogen concentration was 148 mg/dL. The patient was herpes simplex virus type I and II IgG positive according to the TOUCH test. The interleukin 6 concentration was 45.2 pg/mL. Lung CT revealed pulmonary infection, pericardial effusion, left axillary lymph node enlargement, and aortic and coronary atherosclerosis. Abdominal CT showed no obvious abnormalities. Brain CT revealed small ischemic lesions in the left basal ganglia, partial tissue defects in the hard palate and nasal septum, and sinusitis. Brain MRI revealed left basal ganglia lacunae, white matter hyperintensity, and Fazekas grade 1.

3 Initial treatment

The first attempt was to temporarily administer sulfanilamide to prevent infection, and the second was to administer levofloxacin to prevent bacterial infection. Oral leukemia improved through treatment with sodium bicarbonate and Kangfuxin mouthwash. During treatment, the patient experienced intermittent fever, cough, and headache, and still, she had symptoms of nasal reflux; however, with diclofenac suppository treatment, her temperature returned to normal. The next step was to identify the cause of the skin lesions.

4 mNGS testing

Skin biopsy and mNGS were performed at the same time. Pathology revealed that part of the tissue was necrotic, chronic suppurative inflammation with abscess formation and local granulomatous inflammation with multinucleated giant cell reaction. Moreover, all the special staining results, PAS staining, Gram staining, silver staining and acid-fast staining, were negative. The parasite Acanthamoeba castellani, which belongs to the genus Acanthamoeba, was subsequently detected through mNGS without other pathogens being detected (Table 1), mNGS of skin tissue identified 238 sequence reads corresponding to Acanthamoeba castellanii (Figure 1).

Table 1

Table 1 Part of the mNGS test report.

Figure 1

Figure 1 The metagenomic next-generation sequencing (mNGS) results of this patient.

5 Follow-up and outcomes

Based on the mNGS results, the pathologists subsequently reviewed the previous pathological slides and found trophozoites of Acanthamoeba (Figure 2). The laboratory used the previously reported Acanthamoeba-specific primers JDP1 (5′-GGCCCAGATCGTTTACCGTGAA-3′) and JDP2 (5′-TCTCAAGCTGCTAGGGGAGTCA-3′) to specifically amplify Acanthamoeba nucleic acid fragments (Schroeder et al., 2001). Agarose gel electrophoresis confirmed that the amplified target was consistent with the positive control plasmid (Figure 3). Sequence used to construct positive control plasmid was obtained from 18S rRNA gene of Acanthamoeba castellanii neff strain. The sequence was downloaded from GenBank database and synthesized by oligonucleotide manufacturer, the GenBank accession number was U07416.1. The amplified fragment was then subjected to Sanger sequencing, and the sequence was identified as belonging to the T4 genotype through online BLAST analysis.

Figure 2

Figure 2 Trophozoites (black arrow) can be observed in the skin ulcer tissue (light microscope, H&E, ×400).

Figure 3

Figure 3 Agarose electrophoresis showing amplification of Acanthamoeba. (Lanes 1 =  PCR product of the test sample, Lane M = 100 bp DNA ladder, Lane 2 = positive control plasmid, Lane 3 = negative control.).

Combined with the pathological and mNGS results, the clinical doctors gave sulfamethoxazole, voriconazole and metronidazole combination anti-amebic treatment. After multi-drug combination therapy, the skin ulcer dried up and crusted, and subcutaneous mass was significantly smaller than before. The patient was discharged after the afebrile and skin ulcers were better than before.

6 Discussion

Although Acanthamoeba trophozoites have a very characteristic donut-like nucleus due to their large central karyosome, it is sometimes difficult to differentiate them from macrophages solely by histopathology and they may be unrecognized or even misdiagnosed (Murakawa et al., 1995; Morrison et al., 2016). This pathogen was rapidly mapped via mNGS technology, and early detection of infectious pathogens is also conducive to early treatment. The brain MSI results showed no involvement of the central nervous system, and this patient responded well to anti-amoeba drug therapy, which was consistent with the findings of previous studies. Isolated primary cutaneous Acanthamoeba strains have been very rare. Cutaneous acanthamoebiasis is susceptible in immunocompromised patients, the amoebae enter through the skin or the respiratory tract, it disseminate systemically and even invade the central nervous system. Once the central nervous system is infected, therapeutic options are limited and the prognosis is grave (Singhal et al., 2001). The prognosis of cutaneous acanthamoebiasis is related to the infective dose and virulence of Acanthamoeba, the immune status of the host, and the timely treatment. In previous literature, the prognosis of cutaneous acanthamoebiasis is worse in immunocompetent patients than in immunocompromised ones (Sharma et al., 2017). Acanthamoeba species usually cause isolated primary cutaneous infection in immunocompromised patients, whereas in immunocompetent people, the initial cutaneous infection will progressed to fatal granulomatous amebic encephalitis without rapid diagnose and treatment (Paltiel et al., 2004). In the past, the diagnosis of cutaneous Acanthamoeba usually needed to be confirmed by amplifying the target fragment of Acanthamoeba-specific nucleic acid, and this scheme requires clinicians to prejudge the suspected pathogens. The mNGS-based detection scheme does not need to be preset in advance, and the method has high specificity and can quickly locate infectious pathogens, which has shown great value in the diagnosis of rare skin diseases (Stetkevich et al., 2022).

The Acanthamoeba genotype in this patient in the Wuhan area was T4, which is the same as that previously reported for Hong Kong; 90% of the detected Acanthamoeba were of the T4 genotype (Booton et al., 2002). Similar cases have not been previously reported from the Chinese mainland. Because metagenomics can detect the characteristics of bacterial, fungal, and viral parasites at the same time, mNGS is ideal for detecting symbiotic microorganisms, although only Acanthamoeba was detected in this case.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.

Author contributions

WF: Writing – review & editing. PL: Writing – original draft. QW: Data curation, Writing – review & editing. XL: Investigation, Writing – review & editing. BL: Validation, Writing – review & editing. YC: Project administration, Writing – review & editing. YL: Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported in part by the Discipline Cultivation Project of Zhongnan Hospital of Wuhan University (ZNXKPY2022004).

Conflict of interest

Authors PL, XL and YL were employed by company Sinopharm Medical Laboratory (Wuhan) Co., Ltd. Authors QW, BL and YL were employed by company Sinopharm Genomics Technology Co., Ltd.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The authors declare that this study received funding from Sinopharm Medical Laboratory (Wuhan) Co., Ltd. The funder had the following involvement in the study: approval of study design and approval of manuscript for publication.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Booton, G. C., Kelly, D. J., Chu, Y. W., Seal, D. V., Houang, E., Lam, D. S., et al. (2002). 18S ribosomal DNA typing and tracking of Acanthamoeba species isolates from corneal scrape specimens, contact lenses, lens cases, and home water supplies of Acanthamoeba keratitis patients in Hong Kong. J. Clin. Microbiol. 40, 1621–1625. doi: 10.1128/JCM.40.5.1621-1625.2002

PubMed Abstract | CrossRef Full Text | Google Scholar

Borecka, A., Bielawska-Drozd, A., Skotarczak, B., Adamska, M., Cieslik, P., Antos-Bielska, M., et al. (2020). Acanthamoeba - pathogen and vector of highly pathogenic bacteria strains to healthy and immunocompromised individuals. Cent Eur. J. Immunol. 45, 228–232. doi: 10.5114/ceji.2020.97667

PubMed Abstract | CrossRef Full Text | Google Scholar

Galarza, C., Ramos, W., Gutierrez, E. L., Ronceros, G., Teran, M., Uribe, M., et al. (2009). Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients. Int. J. Dermatol. 48, 1324–1329. doi: 10.1111/j.1365-4632.2008.03786.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Marciano-Cabral, F., Cabral, G. (2003). Acanthamoeba spp. as agents of disease in humans. Clin. Microbiol. Rev. 16, 273–307. doi: 10.1128/CMR.16.2.273-307.2003

PubMed Abstract | CrossRef Full Text | Google Scholar

Morrison, A. O., Morris, R., Shannon, A., Lauer, S. R., Guarner, J., Kraft, C. S. (2016). Disseminated acanthamoeba infection presenting with cutaneous lesions in an immunocompromised patient. Am. J. Clin. Pathol. 145, 266–270. doi: 10.1093/ajcp/aqv081

PubMed Abstract | CrossRef Full Text | Google Scholar

Murakawa, G. J., Mccalmont, T., Altman, J., Telang, G. H., Hoffman, M. D., Kantor, G. R., et al. (1995). Disseminated acanthamebiasis in patients with AIDS. Arch. Dermatol. 131, 1291. doi: 10.1001/archderm.1995.01690230069011

PubMed Abstract | CrossRef Full Text | Google Scholar

Paltiel, M., Powell, E., Lynch, J., Baranowski, B., Martins, C. (2004). Disseminated cutaneous acanthamebiasis: a case report and review of the literature. Cutis. 73, 241–248.

PubMed Abstract | Google Scholar

Purssell, A., Lau, R., Boggild, A. K. (2017). Azithromycin and doxycycline attenuation of acanthamoeba virulence in a human corneal tissue model. J. Infect. Dis. 215, 1303–1311. doi: 10.1093/infdis/jiw410

PubMed Abstract | CrossRef Full Text | Google Scholar

Rayamajhee, B., Sharma, S., Willcox, M., Henriquez, F. L., Rajagopal, R. N., Shrestha, G. S., et al. (2022). Assessment of genotypes, endosymbionts and clinical characteristics of Acanthamoeba recovered from ocular infection. BMC Infect. Dis. 22, 757. doi: 10.1186/s12879-022-07741-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Rayamajhee, B., Subedi, D., Peguda, H. K., Willcox, M. D., Henriquez, F. L., Carnt, N. (2021). A systematic review of intracellular microorganisms within acanthamoeba to understand potential impact for infection. Pathogens 10, 225. doi: 10.3390/pathogens10020225

PubMed Abstract | CrossRef Full Text | Google Scholar

Schroeder, J. M., Booton, G. C., Hay, J., Niszl, I. A., Seal, D. V., Markus, M. B., et al. (2001). Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J. Clin. Microbiol. 39, 1903–1911. doi: 10.1128/JCM.39.5.1903-1911.2001

PubMed Abstract | CrossRef Full Text | Google Scholar

Sharma, M., Sudhan, S. S., Sharma, S., Megha, K., Nada, R., Khurana, S. (2017). Osteo-cutaneous acanthamoebiasis in a non-immunocompromised patient with a favorable outcome. Parasitol. Int. 66, 727–730. doi: 10.1016/j.parint.2017.08.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Siddiqui, R., Khan, N. A. (2012). Biology and pathogenesis of acanthamoeba. Parasites Vectors 5, 1–13. doi: 10.1186/1756-3305-5-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Singhal, T., Bajpai, A., Kalra, V., Kabra, S. K., Samantaray, J. C., Satpathy, G., et al. (2001). Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr. Infect. Dis. J. 20, 623–627. doi: 10.1097/00006454-200106000-00016

PubMed Abstract | CrossRef Full Text | Google Scholar

Stetkevich, S. A., Le, S. T., Ford, A. R., Brassard, A., Kiuru, M., Fung, M. A., et al. (2022). Isolated cutaneous acanthamoebiasis under prophylactic anticryptococcal treatment in an immunocompromised patient. JAAD Case Rep. 28, 77–79. doi: 10.1016/j.jdcr.2022.08.008

PubMed Abstract | CrossRef Full Text | Google Scholar